A year-round specialty and scientific platform that unites cardiovascular science, clinical decisions, academic production, education, digital health and interdisciplinary collaboration within one architecture.
Evidence → Decision → Impact
To become an international scientific platform originating from Türkiye that transforms how cardiovascular knowledge is learned, produced, translated into clinical practice and shared across medicine.
The scientific chair status can be updated from the admin panel. A proposal in the founding document is not displayed as an approved appointment.
Clinical excellence, research, education, technology and public impact are integrated into one working system.
High-quality clinical decisions, guideline implementation and complex case management.
Algorithms, case sessionsContinuity from prehospital care through ED and CICU for ACS, shock, PE, aortic disease, arrhythmias and arrest.
Emergency–cardiology joint modelsPCI, CTO, TAVI, structural heart interventions and complication management.
Masterclasses, case libraryAI-ECG, wearables, remote monitoring, imaging AI and digital twin research.
Education + research + validationMulticenter studies, registries, methodology and evidence-based scientific production.
Papers, registries, scientific reportsDevelopment of students, residents and specialists through cases, decisions, simulation and feedback.
Academy, simulation, microlearningCardiometabolic risk, lifestyle, primary care and public cardiovascular health literacy.
Campaigns and health literacyThe scientific backbone of cardiology: masterclasses, cases, guideline-to-practice and clinical algorithms.
Continuous scientific partnership with other specialties through joint meetings, boards, consensus and multicenter projects.
AI and digital cardiology: ECG-AI, wearables, imaging, LLMs and technology validation.
Multicenter clinical research and real-world data network.
Next-generation academic development through Mentor → Project → Abstract → Paper.
Public cardiovascular science program using a Myth → Evidence → Action model.
Simulation, decision laboratories and future clinical/technology experiences with EMDATE integration.
Chest pain, OMI, shock, arrhythmia, syncope, aortic syndromes and PE
Cardiotoxicity, thrombosis, HF, QT and shared follow-up
Hypertension in pregnancy, preeclampsia, PPCM and congenital heart disease
HF-CKD, diuretic resistance, potassium, volume and SGLT2
Diabetes, obesity, lipids, GLP-1, SGLT2 and risk
AF-stroke, PFO, syncope and autonomic dysfunction
Shock, MCS, post-arrest care and hemodynamics
AI-ECG, wearables, sensors, remote monitoring and digital twins
Clinical questions are translated into durable scientific output through standardized data dictionaries, ethics/data governance, analysis plans and publication outputs.
| Program | Focus | Example output / question |
|---|---|---|
| ATLAS-CHEST | ED chest pain / ACS | Decision pathways and clinical outcomes |
| ATLAS-SHOCK | Cardiogenic and mixed shock | Phenotype, POCUS and treatment timing |
| ATLAS-AF | Atrial fibrillation | New AF, anticoagulation and follow-up gaps |
| ATLAS-PE | Pulmonary embolism | Risk stratification and reperfusion practice |
| ATLAS-HF | Acute heart failure | Decongestion and renal response |
| ATLAS-ONCOHEART | Cardio-oncology | Pre-treatment risk and cardiotoxicity surveillance |
| ATLAS-MATERNAL-HEART | Cardio-obstetrics | Cardiovascular follow-up after hypertensive disorders of pregnancy |
| ATLAS-METABOLIC | Cardiometabolic medicine | Integration of obesity/diabetes therapies into cardiovascular practice |
The ATLAS Board manages the institutional framework, compliance and sustainability. The working group scientific chair and core team develop the annual scientific agenda, quality standards, research and education priorities.
Scientific chair agreement, charter, core team and brand validation
CardioCore field leads and initial CardioBridge co-leads
Web domain, first CardioCase and Young ATLAS call
First Research Incubator and ATLAS-CHEST/SHOCK pre-protocol
First CardioBridge joint meeting and Decision Note
CardioAI pilot plan and Cardiology Future Lab working group
ATLAS working groups grow through active human resources, measurable output and scientific quality.
